OD2A Innovative Surveillance CoP Workgroup Resource Repository

ABOUT THIS COMMUNITY OF PRACTICE In partnership with the National Center for Injury Prevention and Control (NCIPC), the Council of State and Territorial Epidemiologists (CSTE) hosts this community of practice among OD2A-funded jurisdictions currently conducting innovative surveillance projects. This OD2A Innovative Surveillance Community of Practice consists of 3 focused workgroups that provide a forum for peer discussion on cross-cutting topics, methods, and challenges/solutions across jurisdictions. ______________________________________________________________________________________________________________________ USING THIS BASECAMP + This Basecamp is a tool that houses previous call slides/recordings and allows members to engage with peers. + The Q/A section may be used to facilitate connections/discussion among members. Engagement could include posting new questions/discussion topics or replying to peer questions/discussions. + Members are encouraged to share helpful resources for peers. Members may post any publicly available resource in this space. Please do not share any proprietary information or upload private documents. _________________________________________________________________________________________________________ CONTACT US Email staff lead, Danielle Boyd (overdose@cste.org) if you have questions about the Innovative Surveillance CoP or about this basecamp site for the group. Join the Innovative Surveillance CoP Listserve HERE: https://app.smartsheet.com/b/form/4a5b9c8d52294a67ae920fca78c6c111

SUD Treatment Reporting Question

Publicly-funded SUD treatment providers report unique, individualized treatment admissions and discharges to state agencies, which then standardize and submit Treatment Episode Data sets to SAMHSA. 
  1. In your state, which agency collects the treatment episode data from the treatment providers? What is your program's relationship with this agency?
  2. What, if any, data is available to you? Please describe the frequency, recency, and granularity of the data.
  3. What opportunities exist to work with this agency to enhance linkage to care surveillance?